Russell Investments Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175K | Sell |
150,990
-1,265
| -0.8% | -$1.47K | ﹤0.01% | 2684 |
|
|
2025
Q1 | $242K | Buy |
152,255
+92,234
| +154% | +$147K | ﹤0.01% | 2535 |
|
|
2024
Q4 | $182K | Buy |
60,021
+37,726
| +169% | +$114K | ﹤0.01% | 2562 |
|
|
2024
Q3 | $82K | Buy |
+22,295
| New | +$82K | ﹤0.01% | 2696 |
|
|
2023
Q4 | – | Sell |
-99,412
| Closed | -$1.99M | – | 3319 |
|
|
2023
Q3 | $1.99M | Sell |
99,412
-6,461
| -6% | -$130K | ﹤0.01% | 1545 |
|
|
2023
Q2 | $2.99M | Buy |
105,873
+50,803
| +92% | +$1.43M | 0.01% | 1331 |
|
|
2023
Q1 | $947K | Sell |
55,070
-18,281
| -25% | -$314K | ﹤0.01% | 1996 |
|
|
2022
Q4 | $1.48M | Sell |
73,351
-6,415
| -8% | -$129K | ﹤0.01% | 1769 |
|
|
2022
Q3 | $1.73M | Buy |
79,766
+1,978
| +3% | +$42.8K | ﹤0.01% | 1634 |
|
|
2022
Q2 | $2.18M | Buy |
77,788
+19,169
| +33% | +$538K | ﹤0.01% | 1541 |
|
|
2022
Q1 | $2.7M | Sell |
58,619
-645
| -1% | -$29.7K | ﹤0.01% | 1478 |
|
|
2021
Q4 | $4.98M | Buy |
59,264
+1,751
| +3% | +$147K | 0.01% | 1252 |
|
|
2021
Q3 | $3.83M | Buy |
57,513
+10,990
| +24% | +$732K | 0.01% | 1410 |
|
|
2021
Q2 | $2.47M | Buy |
46,523
+23,187
| +99% | +$1.23M | ﹤0.01% | 1781 |
|
|
2021
Q1 | $1.01M | Hold |
23,336
| – | – | ﹤0.01% | 2240 |
|
|
2020
Q4 | $1.21M | Buy |
+23,336
| New | +$1.21M | ﹤0.01% | 2037 |
|